Genomic Tests
Comprehensive Genomic Profiling using Next-Generation Sequencing with Machine/deep Learning
Solid Tumors
Liquid Trace™:
Solid Tumor Profile- TAT
5-7 Days - Indications
All solid tumors Chromosomal abnormalities, gene amplifications, HRR
Fusions: ALK, ROS1, RET,
NTRK1/2/3, and more.
BRAF, CIC, EWSR1, PD-L1,
MET exon 14 skipping
and various alternative splicing,
MET, HER2, PIK3CA, PTEN,
Gene amplifications, AKT1, RAS,
HER2, MYC, EGFR, TTV,
T- & B-cell clonality analysis
Monitor therapeutic response
- Sample Type
Peripheral blood - Sample Requirements
Peripheral blood: 8-10 ml.
EDTA tube preferred
CSF: 7-10 mL. Clear tubes - Results Reported
DNA+RNA - Monitoring
- Therapeutic
- Prognostic
- Heterogeneity
- Clinical Trial Matching
Read More
Learn more about this test
Solid Tumor
Profile Plus™- TAT
7-10 Days - Indications
All solid tumors
Fusions: ALK, ROS1, RET,
NTRK1/2/3, and more.
BRAF, CIC, EWSR1, PD-L1,
MET exon 14 skipping
and various alternative splicing, MET, HER2, EGFR,
Gene amplifications, PIK3CA, PTEN, TTV,
AKT1, RAS and HRD
Cancer of unknown primary (CUP)
T- & B-cell clonality analysis
- Sample Type
FFPE - Sample Requirements
1 H&E slide and 6-8 unstained slides, 5-7 microns of tissue fixed with 10% NBF fixative - Results Reported
DNA+RNA - Diagnostic
- Therapeutic
- Prognostic
- Heterogeneity
- Clinical Trial Matching
Read More
Learn more about this test
Solid Tumor
Profile™ 434
DNA Genes
DNA Genes
- TAT
5-7 Days - Indications
All solid tumors:
Mutations in 434 genes, copy number
variation and chromosomal structural
abnormalities, TMB, MSI, HRD
- Sample Type
FFPE - Sample Requirements
1 H&E slide and 6-8 unstained slides, 5-7 microns of tissue fixed with 10% NBF fixative - Results Reported
DNA - Diagnostic
- Therapeutic
- Prognostic
- Heterogeneity
- Clinical Trial Matching
Read More
Learn more about this test
Solid Tumor Fusion / Expression Profile
>1600
RNA Genes
RNA Genes
- TAT
7-10 Days - Indications
All Solid tumors:
Fusion: ALK, ROS1, RET, BRAF,
NTRK1/2/3, FGFR1/2/3/4, CIC,
EWSR1 & other sarcoma genes
Expression: PD-L1, MYC, CCND1,
MET, FGFR1/2/3/4, Ki67, ERBB2, MDM2
Alternative splicing: MET exon 14
skipping, EGFRvIII, NTRK,
Mutations in more than 1600 genes, TTV,
T- & B-cell clonality analysis
- Sample Type
FFPE - Sample Requirements
1 H&E slide and 6-8 unstained slides, 5-7 microns of tissue fixed with 10% NBF fixative - Results Reported
RNA - Diagnostic
- Therapeutic
- Prognostic
- Heterogeneity
- Clinical Trial Matching
Read More
Learn more about this test
Hematology
Liquid Trace™:
Hematology Profile- TAT
5-7 Days - Indications
All hematologic neoplasms
including lymphoma
multiple myeloma, acute lymphoblastic leukemia,
acute myeloid leukemia,
MDS, TTV, CMML, MPN,
VEXAS syndrome, and EBV
Chromosomal abnormalities, and gene amplifications,
T- & B-cell clonality analysis
Monitor therapeutic response
- Sample Type
Peripheral blood - Sample Requirements
Peripheral blood: 8-10 ml.
EDTA tube preferred
CSF: 7-10 mL. Clear tubes - Results Reported
DNA+RNA - Diagnostic
- Therapeutic
- Prognostic
- Heterogeneity
- Clinical Trial Matching
Read More
Learn more about this test
Hematology
Profile Plus™- TAT
7-10 Days - Indications
All hematologic neoplasms including lymphoma
Classification and diagnosis of lymphoma, multiple myeloma, acute lymphoblastic leukemia, and acute myeloid leukemia
Includes IgVH
Chromosomal abnormalities, and gene amplifications, TTV,
T- & B-cell clonality analysis
- Sample Type
Bone marrow,
Peripheral blood,
Fresh tissue - Sample Requirements
Bone marrow: 2ml.
Peripheral blood: 5 ml.
EDTA tube preferred
FFPE: 1 H&E slide and 6-10 unstained slides, 5-7 microns of tissue fixed with 10% NBF fixative - Results Reported
DNA+RNA - Diagnostic
- Therapeutic
- Prognostic
- Heterogeneity
- Clinical Trial Matching
Read More
Learn more about this test
Hematology
Profile™ 302
DNA Genes
DNA Genes
- TAT
5-7 Days - Indications
All hematologic neoplasms
including lymphoma
MDS, CMML, AML, MPN (JAK2, CALR, MPL),
MRD, multiple myeloma, and other
hematologic diseases
- Sample Type
Bone marrow,
Peripheral blood,
Fresh tissue - Sample Requirements
Bone marrow: 2ml.
Peripheral blood: 5 ml.
EDTA tube preferred
FFPE: 1 H&E slide and 6-10 unstained slides, 5-7 microns of tissue fixed with 10% NBF fixative - Results Reported
DNA - Diagnostic
- Therapeutic
- Prognostic
- Heterogeneity
- Clinical Trial Matching
Read More
Learn more about this test